Risk Factors for Infection-Attributable Mortality in Patients With Staphylococcus aureus Bacteremia: A Competing Risk Analysis

被引:0
|
作者
Bae, Seongman [1 ,2 ]
Kook, Min Soo [1 ]
Chang, Euijin [1 ]
Jung, Jiwon [1 ]
Kim, Min Jae [1 ]
Chong, Yong Pil [1 ]
Kim, Sung-Han [1 ]
Choi, Sang-Ho [1 ]
Lee, Sang-Oh [1 ]
Kim, Yang Soo [1 ,2 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Infect Dis,Coll Med, 88 Olymp ro 43 gil, Seoul 05505, South Korea
[2] Univ Ulsan, Coll Med, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea
来源
OPEN FORUM INFECTIOUS DISEASES | 2025年 / 12卷 / 01期
关键词
attributable death; competing risk analysis; risk factor; Staphylococcus aureus; S. aureus bacteremia; BLOOD-STREAM INFECTIONS; METHICILLIN-RESISTANT; GUIDELINES; PREDICTORS; DIAGNOSIS;
D O I
10.1093/ofid/ofae734
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Identifying risk factors for mortality in patients with Staphylococcus aureus bacteremia (SAB) is crucial due to its high fatality. However, data on risk factors for infection-attributable deaths considering competing risk events such as non-infection-attributable deaths remain limited. We performed a competing risk analysis to elucidate risk factors associated with 30-day infection-attributable mortality in a large cohort of patients with SAB.Methods This retrospective cohort study included adult patients diagnosed with SAB at a tertiary hospital from August 2008 to December 2019. Competing risk analysis was performed using Fine and Gray models to estimate subdistribution hazard ratios (sHRs) for 30-day infection-attributable death.Results Among 1936 patients, 444 (22.9%) died within 30 days. Of these, 338 (76.1%) were infection-attributable and 106 (23.9%) were non-infection-attributable deaths. The multivariable Fine and Gray model identified significant risk factors for 30-day infection-attributable death (sHRs with 95% confidence intervals): an increase in age by 10 years (1.14 [1.02-1.26]), presence of malignancy (1.54 [1.17-2.02]), liver cirrhosis (2.15 [1.56-2.97]), corticosteroid use (1.61 [1.19-2.17]), septic shock (3.28 [1.98-5.42]), elevated C-reactive protein (1.60 [1.19-2.14]), pneumonia (1.81 [1.21-2.72]), persistent bacteremia (1.73 [1.31-2.30]), and failure to remove the eradicable focus (2.40 [1.38-4.19]) or absence of an eradicable focus (1.49 [1.08-2.04]). Except for age and malignancy, these factors were not significantly associated with non-infection-related death.Conclusions Specific risk factors for infection-attributable death in patients with SAB were identified, distinct from those for nonattributable death. These findings can aid in the early identification of patients at risk for SAB-attributable mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia
    Hill, Evelyn E.
    Vanderschueren, Steven
    Verhaegen, Jan
    Herijgers, Paul
    Claus, Piet
    Herregods, Marie-Christine
    Peetermans, Willy E.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (10) : 1165 - 1169
  • [22] Frequency and risk factors for deep focus of infection in children with Staphylococcus aureus bacteremia
    Ross, Allison C.
    Toltzis, Philip
    O'Riordan, Mary Ann
    Millstein, Leah
    Sands, Troy
    Reapath, Allison
    John, Chandy
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (05) : 396 - 399
  • [23] Risk Factors for Persistent Staphylococcus aureus Bacteremia in Children
    Thornley, Erin M.
    Alexander, Robin
    Popelka, Jill
    Montgomery, Christopher P.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (11) : 1040 - 1045
  • [24] Risk Factors for Complications in Children with Staphylococcus aureus Bacteremia
    Hamdy, Rana F.
    Dona, Daniele
    Jacobs, Marni B.
    Gerber, Jeffrey S.
    JOURNAL OF PEDIATRICS, 2019, 208 : 214 - +
  • [25] Staphylococcus aureus Bacteremia, Risk Factors, Complications, and Management
    Keynan, Yoav
    Rubinstein, Ethan
    CRITICAL CARE CLINICS, 2013, 29 (03) : 547 - +
  • [26] Risk factors associated with persistence of staphylococcus aureus bacteremia
    Kitazawa, T.
    Seo, K.
    Koga, I.
    Ota, Y.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 139 - 139
  • [27] Clinical Presentation, Risk Factors, and Outcomes of Hematogenous Prosthetic Joint Infection in Patients with Staphylococcus aureus Bacteremia
    Tande, Aaron J.
    Palraj, Bharath Raj
    Osmon, Douglas R.
    Berbari, Elie F.
    Baddour, Larry M.
    Lohse, Christine M.
    Steckelberg, James M.
    Wilson, Walter R.
    Sohail, M. Rizwan
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (02): : 221.e11 - 221.e20
  • [28] Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia
    Kinamon, Tori
    Dagher, Michael
    Park, Lawrence
    Ruffin, Felicia
    Fowler Jr, Vance G.
    Maskarinec, Stacey A.
    CLINICAL INFECTIOUS DISEASES, 2023, : 1226 - 1233
  • [29] Risk factors for hospital-acquired Staphylococcus aureus bacteremia
    Jensen, AG
    Wachmann, CH
    Poulsen, KB
    Espersen, F
    Scheibel, J
    Skinhoj, P
    Frimodt-Moller, N
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (13) : 1437 - 1444
  • [30] Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia
    Salvador, Vincent Bryan D.
    Chapagain, Bikash
    Joshi, Astha
    Brennessel, Debra J.
    TEXAS HEART INSTITUTE JOURNAL, 2017, 44 (01): : 10 - 15